[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"medication-compliance\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:medication-compliance":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,50,79],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100497792","pediatric-medication-therapy-management-trial-100497792",false,"NCT05761847","Pediatric Medication Therapy Management Trial","Optimizing the Clinical Management of Polypharmacy for Children With Medical Complexity: The Pediatric Medication Therapy Management (pMTM) Trial","pMTM","Inclusion Criteria:\n\n* 2-18 years old\n* ≥1 complex chronic condition (CCC)\n* ≥5 current medications (including prescription, as needed, and over-the-counter medications)\n* Receives primary care at Children's Hospital Colorado\n\nExclusion Criteria:\n\n* Non-English speaking\n* Sibling or family member already enrolled in this study","ALL","2 Years","18 Years",{"count":21,"type":22},371,"ESTIMATED","INTERVENTIONAL",[25],"NA","The purpose of this study is to evaluate whether an intervention called Pediatric Medication Therapy Management (pMTM) improves the identification and management of medication-related problems among children with medical complexity and polypharmacy.",[28,29,30,31,32],"Child, Only","Disabilities Multiple","Medication Interaction","Medication Compliance","Medication Administered in Error",[34,35,36],"Children with Medical Complexity","Polypharmacy","Medication Safety","RECRUITING","2026-04-27",{"date":40,"type":41},"2026-04-28","ACTUAL",{"date":43,"type":41},"2023-09-11",{"date":45,"type":22},"2028-01-31",{"name":47,"class":48},"University of Colorado, Denver","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":19,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":59,"briefSummary":60,"conditions":61,"keywords":65,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":49},"100590761","telehealth-monitoring-in-inflammatory-bowel-disease-effects-on-medication-compliance-self-efficacy-and-quality-of-life-100590761","NCT06971627","Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life","The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease","Inclusion Criteria:\n\n* Individuals aged 18 years or older\n* Individuals aged 18 years or older\n* Able to read and write in Turkish\n* Diagnosed with inflammatory bowel disease (IBD) for at least 6 months\n* In clinical remission (Harvey-Bradshaw Index score \\\u003C 5 or Simple Clinical Colitis Activity Index score \\\u003C 3)\n* Able to use a smartphone\n* Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address\n* Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)\n* Willing to participate in the study voluntarily\n\nExclusion Criteria:\n\n* Diagnosed with any psychiatric or cognitive disorder\n* Having any condition that impairs communication\n* Pregnant women\n* Patients receiving infusion-based treatment\n* Having an advanced chronic disease",{"count":58,"type":22},120,[25],"This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.",[62,31,63,64],"Inflammatory Bowel Disease (IBD)","Quality of Life","Telehealth Monitoring",[66,31,67,63,64,68,69],"Inflammatory Bowel Disease","Self-Efficacy","Crohn's Disease","Ulcerative colitis","2025-05-07",{"date":72,"type":41},"2025-05-14",{"date":74,"type":41},"2024-04-20",{"date":76,"type":22},"2025-05-30",{"name":78,"class":48},"Istanbul University - Cerrahpasa",{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":4,"eligibilityCriteria":85,"healthyVolunteers":11,"sex":17,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":90,"briefSummary":91,"conditions":92,"keywords":96,"overallStatus":98,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":4},"100347527","studiio-diabetes-pilot-study-of-drug-insurance-to-improve-outcomes-of-diabetes-100347527","NCT03804905","STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes","A Pilot Pragmatic Randomized Controlled Trial to Evaluate the Impact of Improving Access to Drugs on Type 2 Diabetes Care, Outcomes and Costs","Inclusion Criteria:\n\n* clinical diagnosis of type 2 diabetes record in family physician's electronic medical record\n* lack of medication insurance\n\nExclusion Criteria:\n\n\\-","25 Years","64 Years",{"count":89,"type":22},144,[25],"Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face other barriers to good health: low income, new immigrants, single mothers, etc. For these patients, taking prescription drugs - especially chronic disease treatments that may be required lifelong - can be difficult due to high costs. Patients skip doses, delay renewing prescriptions, or simply do not fill prescriptions recommended by their doctors, because they do not have insurance to cover the costs of prescriptions. Previous research by the study team has suggested that the lack of a universal drug insurance program for working-age Canadians affects the health and well-being of low-income people with diabetes. The goal of this research is to determine the clinical and economic impact of providing drug coverage for uninsured type 2 diabetics.",[93,94,31,95],"Type 2 Diabetes Mellitus","Medication Adherence","Medication Nonadherence",[93,31,97],"Medication Insurance","NOT_YET_RECRUITING","2024-12-19",{"date":101,"type":41},"2024-12-24",{"date":103,"type":22},"2026-01-01",{"date":105,"type":22},"2026-12-31",{"name":107,"class":48},"Sunnybrook Health Sciences Centre"]